| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6184193 | Gynecologic Oncology | 2015 | 5 Pages |
Abstract
This was a large, prospective study designed to measure cognitive function in ovarian cancer. A subset of patients had evidence of cognitive decline from baseline during chemotherapy treatment in this study as measured by the web-based assessment; however, changes were generally limited to no more than one domain.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Lisa M. Hess, Helen Q. Huang, Alexandra L. Hanlon, William R. Robinson, Rhonda Johnson, Setsuko K. Chambers, Robert S. Mannel, Larry Puls, Susan A. Davidson, Michael Method, Shashikant Lele, Laura Havrilesky, Tina Nelson, David S. Alberts,